Gregory T. Went, Chief Executive Officer, 10% Owner at Adamas Pharmaceuticals Inc (ADMS), sold 23,088 shares at $18.00 ($416K) on 2015-03-19, disclosed to the SEC on 2015-03-19.
Scheduled sale ($416k) by Chief Executive Officer, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.00 | 1,900 | $34K | 8.2% |
| 2 | $18.00 | 2,700 | $49K | 11.7% |
| 3 | $18.00 | 4,600 | $83K | 19.9% |
| 4 | $18.00 | 9,420 | $170K | 40.8% |
| 5 | $18.00 | 2,148 | $39K | 9.3% |
| 6 | $18.00 | 2,320 |
| $42K |
| 10.0% |
| Total | $18.00 avg | 23,088 | $416K | 100% |
| Filing → |
| ADMS | SELL | 2018-03-22 | $234K | — | Filing → |
| ADMS | SELL | 2017-03-22 | $48K | — | Filing → |
| ADMS | SELL | 2015-05-14 | $49K | — | Filing → |